Quest Diagnostics
From Wikipedia, the free encyclopedia
| Quest Diagnostics | |
|---|---|
 |
|
| Type | Public (NYSE: DGX) |
| Founded | New York, U.S. (1969) |
| Headquarters | Madison, New Jersey, U.S. |
| Key people | Surya Mohapatra (CEO) |
| Services | Clinical laboratory |
| Website | QuestDiagnostics.com |
Quest Diagnostics Incorporated (NYSE: DGX) is a United States corporation which provides clinical laboratory services. The company has operations in the United States, United Kingdom, Mexico and through its wholly-owned subsidiary Quest Diagnostics India Pvt. Ltd, a laboratory in India[1] in addition to service locations located in Brazil. Quest Diagnostics also has collaborative agreements internationally with various hospitals and clinics. [2] Quest Diagnostics also has operations in the US Territory of Puerto Rico. [3]
Quest Diagnostics is a member of the Fortune 500 and the S&P 500. The company's corporate headquarters were previously located in Teterboro, New Jersey where the largest business unit is located. Currently, the corporate headquarters are located in Madison, New Jersey[4] having moved there in October 2007 from Lyndhurst, New Jersey.
Contents |
[edit] History
- 1969: Founded as MetPath, Inc., in New York.
- 1982: MetPath was acquired by what was then known as Corning Glass Works, and subsequently renamed Corning Clinical Laboratories.
- 1997: Quest Diagnostics becomes an independent company as a spin-off from Corning.
- 1997: Acquires clinical laboratory division of Branford, CT-based Diagnostic Medical Laboratory, Inc. (DML)[5].
- 1999: Acquires SmithKline Beecham Clinical Laboratories; GlaxoSmithKline still holds a large portion of Quest Diagnostics stock.
- 2001: Completes acquisition of Ohio-based MedPlus, Inc. (NASDAQ: MEDP), a healthcare technology company.
- 2002: Completes acquisition of Virginia-based American Medical Laboratories, Inc. (AML) and an affiliated company of AML, LabPortal, Inc., for approximately $500 million in cash.
- 2003: Completes acquisition of California-based Unilab Corporation (NASDAQ: ULAB) in a transaction valued at approximately $800 million .
- 2005: Completes acquisition of Kansas-based LabOne, Inc. (NASDAQ: LABS).
- 2006: Completes acquisition of Virginia-based Focus Diagnostics, Inc., an infectious and immunologic disease laboratory, for approximately $185 million in cash.
- 2007: Quest Diagnostics celebrates its 10th year after being spun off from Corning.
- 2007: Completes acquisition of Sweden-based Hemocue, a point-of-care diagnostic testing company.
- 2007: Acquires AmeriPath, becoming the leading provider of cancer diagnostic testing services.
[edit] Key Facts
- The nation's leading provider of diagnostic testing, information and services.
- Processed more than 151 million test requisitions in 2006.
- More than 33 regional laboratories in key U.S. markets, plus the UK and Mexico.
- Approximately 2,000 patient service centers.
- Revenues of approximately $6.7 billion in 2007.
- Leadership in gene-based and esoteric testing.
- Leadership in workplace drug testing.
[edit] See also
[edit] External links
[edit] References
- ^ 2/20/2008 News Release: Birla Sun Life Insurance Names Quest Diagnostics its Exclusive Provider of Health Assessment Services in India. http://phx.corporate-ir.net/phoenix.zhtml?c=82068&p=irol-newsArticle&ID=1110178&highlight=India
- ^ Quest Diagnostics: Our Growing International Presence http://www.questdiagnostics.com/brand/business/b_bus_lab_presence.html
- ^ Quest Diagnostics: International Facilities & Operations http://www.questdiagnostics.com/brand/company/b_comp_intl_facilities.html
- ^ 10/24/2007 News Release: Quest Diagnostics Reports Third Quarter Results. Note new location of press release http://phx.corporate-ir.net/phoenix.zhtml?c=82068&p=irol-newsArticle&ID=1066622&highlight=
- ^ Quest Diagnostics Acquires Assets Of Diagnostics Medical Laboratory Inc. http://phx.corporate-ir.net/phoenix.zhtml?c=82068&p=irol-newsArticle&ID=199488&highlight=
